Attached files

file filename
EX-3.01 - EXHIBIT 3.01 - MultiCell Technologies, Inc.v321263_ex3-01.htm

 

UNITED STATES

SECURITIES AND EXCHANGE

COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

August 10, 2012

  


 

MULTICELL TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-10221   52-1412493
(State or other jurisdiction of incorporation)   (Commission  File Number)   (IRS Employer
Identification No.)

 

68 Cumberland Street, Suite 301

Woonsocket, Island 02895

(Address of principal executive offices, including zip code)

 

(401) 762-0045

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 

Item 5.07.Submission of Matters to a Vote of Security Holders.

 

The Company held its Annual Meeting of Stockholders on August 10, 2012, to consider and vote on the matters listed below. The proposals are described in detail in the Proxy Statement filed with the Securities and Exchange Commission on July 11, 2012. The final voting results from the meeting are set forth below.

 

Proposal 1: Election of Directors

 

Based on the following votes, the individuals named below were each elected to serve as directors until the Company’s next annual meeting of stockholders.

 

Name

Votes For

Votes

Withheld

Broker Non-Votes

W. Gerald Newmin

81,748,727

6,690,634

590,733,215

Thomas A. Page

79,294,252

9,145,109

590,733,215

Edward Sigmond

79,289,252

9,150,109

590,733,215

Stephen Chang, Ph. D.

78,940,750

9,498,611

590,733,215

Anthony E. Altig

79,293,252

9,146,109

590,733,215

 

Proposal 2: Ratification of Selection of Independent Auditors

 

The proposal ratifies the selection of Hanson Barnett & Maxwell P.C. as the Company’s Independent Registered Public Accounting Firm. The results of the voting included 646,605,519 votes for, 26,722,975 votes against, 5,844,082 votes abstained and no non-votes. The selection was ratified.

 

Proposal 3: Approval of the Certificate of Amendment of the Company’s Amended and Restated Certificate of Incorporation

 

This proposal amends and restates the Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock to a total of 3.0 billion shares and ratify certain prior increases in the number of authorized shares. The results of the voting included 524,292,060 votes for, 150,292,965 votes against, 4,587,551 votes abstained and no non-votes. The amendment was approved.

 

Item 9.01.Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
3.01   Certificate of Amendment of the Amended and Restated Certificate of Incorporation
     

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MULTICELL TECHNOLOGIES, INC.
     
  By: /s/ W. Gerald Newmin  
   

W. Gerald Newmin

Chief Executive Officer, Chief Financial Officer

 

Date: August 13, 2012